{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T04:28:59Z","timestamp":1786595339299,"version":"build-2736575974"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T00:00:00Z","timestamp":1780790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["952183"],"award-info":[{"award-number":["952183"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"name":"PNRR-HEAL ITALIA \u2013 Spoke 5 \u2013 Next Gen Therapeutics","award":["ORGANO-CAR"],"award-info":[{"award-number":["ORGANO-CAR"]}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PRIN 2017E3A2NR_004"],"award-info":[{"award-number":["PRIN 2017E3A2NR_004"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04628-3","type":"journal-article","created":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T07:05:17Z","timestamp":1780815917000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Red blood cell-derived extracellular vesicles enable cisplatin and cetuximab combined therapy against triple-negative breast cancer"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3972-460X","authenticated-orcid":false,"given":"Miriam","family":"Romano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6193-4366","authenticated-orcid":false,"given":"Angelo","family":"Music\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4117-6662","authenticated-orcid":false,"given":"Selene","family":"Tassoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4410-5272","authenticated-orcid":false,"given":"Lucia","family":"Paolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3626-0360","authenticated-orcid":false,"given":"Andrea","family":"Zendrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrica","family":"Gilberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Orlandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Pedrazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2611-1844","authenticated-orcid":false,"given":"Silvia","family":"Alacqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9744-4681","authenticated-orcid":false,"given":"Agnese","family":"Segala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7743-0397","authenticated-orcid":false,"given":"Rossella","family":"Zenatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2819-1171","authenticated-orcid":false,"given":"Ingrid","family":"Cifola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4040-4654","authenticated-orcid":false,"given":"Eleonora","family":"Mangano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9328-9557","authenticated-orcid":false,"given":"Clarissa","family":"Consolandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Camboni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7695-3471","authenticated-orcid":false,"given":"Lorena","family":"Signati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6904-8895","authenticated-orcid":false,"given":"Serena","family":"Mazzucchelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2593-3785","authenticated-orcid":false,"given":"Arabella","family":"Neva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6548-741X","authenticated-orcid":false,"given":"Maurizio","family":"Ragni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8655-1206","authenticated-orcid":false,"given":"Marco","family":"Severgnini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5844-2256","authenticated-orcid":false,"given":"Alessandra","family":"Valerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3029-7063","authenticated-orcid":false,"given":"Giuseppe","family":"Pomarico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9438-2569","authenticated-orcid":false,"given":"Camillo","family":"Almici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"De Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6469-4086","authenticated-orcid":false,"given":"Fabio","family":"Corsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4652-2168","authenticated-orcid":false,"given":"Paolo","family":"Bergese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2737-1090","authenticated-orcid":false,"given":"Annalisa","family":"Radeghieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,7]]},"reference":[{"key":"4628_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2147\/BCTT.S348060","volume":"14","author":"M Maqbool","year":"2022","unstructured":"Maqbool M, Bekele F, Fekadu G. Treatment Strategies Against Triple-Negative Breast Cancer: An Updated Review. Breast Cancer Targets Ther. 2022;14:15\u201324. https:\/\/doi.org\/10.2147\/BCTT.S348060.","journal-title":"Breast Cancer Targets Ther"},{"key":"4628_CR2","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","volume":"740","author":"S Dasari","year":"2014","unstructured":"Dasari S, Bernard Tchounwou P. Cisplatin in cancer therapy: Molecular mechanisms of action. Eur J Pharmacol. 2014;740:364\u201378. https:\/\/doi.org\/10.1016\/j.ejphar.2014.07.025.","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"4628_CR3","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1200\/JCO.2009.22.4725","volume":"28","author":"DP Silver","year":"2010","unstructured":"Silver DP, Richardson AL, Eklund AC, Wang ZC, Szallasi Z, Li Q, et al. Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer. J Clin Oncol. 2010;28(7):1145\u201353. https:\/\/doi.org\/10.1200\/JCO.2009.22.4725.","journal-title":"J Clin Oncol"},{"issue":"1","key":"4628_CR4","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.1038\/s41467-022-31704-7","volume":"13","author":"B Wang","year":"2022","unstructured":"Wang B, Sun T, Zhao Y, Wang S, Zhang J, Wang Z, et al. A randomized phase 3 trial of Gemcitabine or Nab-paclitaxel combined with cisPlatin as first-line treatment in patients with metastatic triple-negative breast cancer. Nat Commun. 2022;13(1):4025. https:\/\/doi.org\/10.1038\/s41467-022-31704-7.","journal-title":"Nat Commun"},{"issue":"1","key":"4628_CR5","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1186\/s12885-019-6278-9","volume":"19","author":"DP Hill","year":"2019","unstructured":"Hill DP, Harper A, Malcolm J, McAndrews MS, Mockus SM, Patterson SE, et al. Cisplatin-resistant triple-negative breast cancer subtypes: multiple mechanisms of resistance. BMC Cancer. 2019;19(1):1039. https:\/\/doi.org\/10.1186\/s12885-019-6278-9.","journal-title":"BMC Cancer"},{"issue":"2","key":"4628_CR6","doi-asserted-by":"publisher","first-page":"445","DOI":"10.4143\/crt.2016.572","volume":"50","author":"J Guo","year":"2018","unstructured":"Guo J, Xu B, Han Q, Zhou H, Xia Y, Gong C, et al. Ferroptosis: A Novel Anti-tumor Action for Cisplatin. Cancer Res Treat. 2018;50(2):445\u201360. https:\/\/doi.org\/10.4143\/crt.2016.572.","journal-title":"Cancer Res Treat"},{"key":"4628_CR7","doi-asserted-by":"publisher","first-page":"1284057","DOI":"10.3389\/fimmu.2023.1284057","volume":"14","author":"J Li","year":"2023","unstructured":"Li J, He D, Li S, Xiao J, Zhu Z. Ferroptosis: the emerging player in remodeling triple-negative breast cancer. Front Immunol. 2023;14:1284057. https:\/\/doi.org\/10.3389\/fimmu.2023.1284057.","journal-title":"Front Immunol"},{"key":"4628_CR8","doi-asserted-by":"publisher","first-page":"1402514","DOI":"10.3389\/fphar.2024.1402514","volume":"15","author":"R Chen","year":"2024","unstructured":"Chen R, Zhu S, Zhao R, Liu W, Jin L, Ren X, et al. Targeting ferroptosis as a potential strategy to overcome the resistance of cisplatin in oral squamous cell carcinoma. Front Pharmacol. 2024;15:1402514. https:\/\/doi.org\/10.3389\/fphar.2024.1402514.","journal-title":"Front Pharmacol"},{"issue":"1","key":"4628_CR9","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41523-022-00468-0","volume":"8","author":"P Zagami","year":"2022","unstructured":"Zagami P, Carey LA. Triple negative breast cancer: Pitfalls and progress. Npj Breast Cancer. 2022;8(1):95. https:\/\/doi.org\/10.1038\/s41523-022-00468-0.","journal-title":"Npj Breast Cancer"},{"issue":"8","key":"4628_CR10","doi-asserted-by":"publisher","first-page":"112945","DOI":"10.1016\/j.celrep.2023.112945","volume":"42","author":"Z Yang","year":"2023","unstructured":"Yang Z, Su W, Wei X, Qu S, Zhao D, Zhou J, et al. HIF-1\u03b1 drives resistance to ferroptosis in solid tumors by promoting lactate production and activating SLC1A1. Cell Rep. 2023;42(8):112945. https:\/\/doi.org\/10.1016\/j.celrep.2023.112945.","journal-title":"Cell Rep"},{"issue":"12","key":"4628_CR11","doi-asserted-by":"publisher","first-page":"10611","DOI":"10.3168\/jds.2024-24822","volume":"107","author":"Y Fan","year":"2024","unstructured":"Fan Y, Ma L, Fang X, Du S, Mauck J, Loor JJ, et al. Role of hypoxia-inducible-factor-1\u03b1 (HIF-1\u03b1) in ferroptosis of adipose tissue during ketosis. J Dairy Sci. 2024;107(12):10611\u201327. https:\/\/doi.org\/10.3168\/jds.2024-24822.","journal-title":"J Dairy Sci"},{"issue":"3","key":"4628_CR12","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.jtho.2020.11.022","volume":"16","author":"MB Nilsson","year":"2021","unstructured":"Nilsson MB, Robichaux J, Herynk MH, Cascone T, Le X, Elamin Y, et al. Altered Regulation of HIF-1\u03b1 in Naive- and Drug-Resistant EGFR-Mutant NSCLC: Implications for a Vascular Endothelial Growth Factor-Dependent Phenotype. J Thorac Oncol. 2021;16(3):439\u201351. https:\/\/doi.org\/10.1016\/j.jtho.2020.11.022.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"4628_CR13","doi-asserted-by":"publisher","first-page":"3182","DOI":"10.1038\/s41467-021-23042-x","volume":"12","author":"S Roy","year":"2021","unstructured":"Roy S, Rizvi ZA, Clarke AJ, Macdonald F, Pandey A, Zaiss DMW, et al. EGFR-HIF1\u03b1 signaling positively regulates the differentiation of IL-9 producing T helper cells. Nat Commun. 2021;12(1):3182. https:\/\/doi.org\/10.1038\/s41467-021-23042-x.","journal-title":"Nat Commun"},{"issue":"1","key":"4628_CR14","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.1038\/s41598-023-30950-z","volume":"13","author":"C Mamot","year":"2023","unstructured":"Mamot C, Wicki A, Hasler-Strub U, Riniker S, Li Q, Holer L, et al. A multicenter phase II trial of anti-EGFR-immunoliposomes loaded with doxorubicin in patients with advanced triple negative breast cancer. Sci Rep. 2023;13(1):3705. https:\/\/doi.org\/10.1038\/s41598-023-30950-z.","journal-title":"Sci Rep"},{"issue":"5","key":"4628_CR15","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1158\/2767-9764.CRC-22-0443","volume":"3","author":"R Chaudhary","year":"2023","unstructured":"Chaudhary R, Slebos RJC, Noel LC, Song F, Poole MI, Hoening DS, et al. EGFR Inhibition by Cetuximab Modulates Hypoxia and IFN Response Genes in Head and Neck Squamous Cell Carcinoma. Cancer Res Commun. 2023;3(5):896\u2013907. https:\/\/doi.org\/10.1158\/2767-9764.CRC-22-0443.","journal-title":"Cancer Res Commun"},{"issue":"1","key":"4628_CR16","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.canlet.2012.02.012","volume":"322","author":"H Lu","year":"2012","unstructured":"Lu H, Liang K, Lu Y, Fan Z. The anti-EGFR antibody cetuximab sensitizes human head and neck squamous cell carcinoma cells to radiation in part through inhibiting radiation-induced upregulation of HIF-1\u03b1. Cancer Lett. 2012;322(1):78\u201385. https:\/\/doi.org\/10.1016\/j.canlet.2012.02.012.","journal-title":"Cancer Lett"},{"key":"4628_CR17","doi-asserted-by":"publisher","first-page":"113861","DOI":"10.1016\/j.biopha.2022.113861","volume":"156","author":"Q Liu","year":"2022","unstructured":"Liu Q, Guan C, Liu C, Li H, Wu J, Sun C. Targeting hypoxia-inducible factor-1alpha: A new strategy for triple-negative breast cancer therapy. Biomed Pharmacother. 2022;156:113861. https:\/\/doi.org\/10.1016\/j.biopha.2022.113861.","journal-title":"Biomed Pharmacother"},{"issue":"20","key":"4628_CR18","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1200\/JCO.2012.46.2408","volume":"31","author":"J Baselga","year":"2013","unstructured":"Baselga J, G\u00f3mez P, Greil R, Braga S, Climent MA, Wardley AM, et al. Randomized Phase II Study of the Anti\u2013Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab With Cisplatin Versus Cisplatin Alone in Patients With Metastatic Triple-Negative Breast Cancer. J Clin Oncol. 2013;31(20):2586\u201392. https:\/\/doi.org\/10.1200\/JCO.2012.46.2408.","journal-title":"J Clin Oncol"},{"issue":"22","key":"4628_CR19","doi-asserted-by":"publisher","first-page":"13566","DOI":"10.1021\/acs.chemrev.7b00258","volume":"117","author":"W Fan","year":"2017","unstructured":"Fan W, Yung B, Huang P, Chen X. Nanotechnology for Multimodal Synergistic Cancer Therapy. Chem Rev. 2017;117(22):13566\u2013638. https:\/\/doi.org\/10.1021\/acs.chemrev.7b00258.","journal-title":"Chem Rev"},{"key":"4628_CR20","doi-asserted-by":"publisher","first-page":"102215","DOI":"10.1016\/j.mtbio.2025.102215","volume":"34","author":"P Shen","year":"2025","unstructured":"Shen P, Huang K, Zhang X, Yin G, Qin M, Ma H, et al. Genetically engineered MSC-derived hybrid cellular vesicles for ROS-scavenging and mitochondrial homeostasis in hepatic ischemia-reperfusion injury. Mater Today Bio. 2025;34:102215. https:\/\/doi.org\/10.1016\/j.mtbio.2025.102215.","journal-title":"Mater Today Bio"},{"key":"4628_CR21","doi-asserted-by":"publisher","first-page":"106850","DOI":"10.1016\/j.jddst.2025.106850","volume":"107","author":"T Geng","year":"2025","unstructured":"Geng T, Ding L, Liu M, Zou X, Gu Z, Lin H, et al. Preservation of extracellular vesicles for drug delivery: A comparative evaluation of storage buffers. J Drug Deliv Sci Technol. 2025;107:106850. https:\/\/doi.org\/10.1016\/j.jddst.2025.106850.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"6","key":"4628_CR22","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1021\/acsinfecdis.8b00030","volume":"4","author":"A Goes","year":"2018","unstructured":"Goes A, Fuhrmann G. Biogenic and Biomimetic Carriers as Versatile Transporters To Treat Infections. ACS Infect Dis. 2018;4(6):881\u201392. https:\/\/doi.org\/10.1021\/acsinfecdis.8b00030.","journal-title":"ACS Infect Dis"},{"key":"4628_CR23","doi-asserted-by":"publisher","first-page":"810761","DOI":"10.3389\/fmed.2022.810761","volume":"9","author":"G Zhou","year":"2022","unstructured":"Zhou G, Gu Y, Zhu Z, Zhang H, Liu W, Xu B, et al. Exosome Mediated Cytosolic Cisplatin Delivery Through Clathrin-Independent Endocytosis and Enhanced Anti-cancer Effect via Avoiding Endosome Trapping in Cisplatin-Resistant Ovarian Cancer. Front Med. 2022;9:810761. https:\/\/doi.org\/10.3389\/fmed.2022.810761.","journal-title":"Front Med"},{"issue":"2","key":"4628_CR24","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/s41578-020-00277-6","volume":"6","author":"KW Witwer","year":"2021","unstructured":"Witwer KW, Wolfram J. Extracellular vesicles versus synthetic nanoparticles for drug delivery. Nat Rev Mater. 2021;6(2):103\u20136. https:\/\/doi.org\/10.1038\/s41578-020-00277-6.","journal-title":"Nat Rev Mater"},{"issue":"21","key":"4628_CR25","doi-asserted-by":"publisher","first-page":"21639","DOI":"10.1021\/acsnano.3c06803","volume":"17","author":"MK Jayasinghe","year":"2023","unstructured":"Jayasinghe MK, Gao C, Yap G, Yeo BZJ, Vu LT, Tay DJW, et al. Red Blood Cell-Derived Extracellular Vesicles Display Endogenous Antiviral Effects and Enhance the Efficacy of Antiviral Oligonucleotide Therapy. ACS Nano. 2023;17(21):21639\u201361. https:\/\/doi.org\/10.1021\/acsnano.3c06803.","journal-title":"ACS Nano"},{"key":"4628_CR26","doi-asserted-by":"publisher","unstructured":"Paolini L, Romano M, Mangolini V, Tassoni S, Jiang S, Mazzoldi EL, et al. Red blood cell-derived extracellular vesicles as biomaterials: the opportunity of freezing-induced accelerated aging. Biomater. Sci. 2026;14:122\u2013139. https:\/\/doi.org\/10.1039\/D5BM01349F.","DOI":"10.1039\/D5BM01349F"},{"issue":"9","key":"4628_CR27","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1021\/cr980421n","volume":"99","author":"ER Jamieson","year":"1999","unstructured":"Jamieson ER, Lippard SJ. Structure, Recognition, and Processing of Cisplatin\u2009\u2013\u2009DNA Adducts. Chem Rev. 1999;99(9):2467\u201398. https:\/\/doi.org\/10.1021\/cr980421n.","journal-title":"Chem Rev"},{"issue":"4","key":"4628_CR28","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nrd1691","volume":"4","author":"D Wang","year":"2005","unstructured":"Wang D, Lippard SJ. Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov. 2005;4(4):307\u201320. https:\/\/doi.org\/10.1038\/nrd1691.","journal-title":"Nat Rev Drug Discov"},{"issue":"18","key":"4628_CR29","doi-asserted-by":"publisher","first-page":"4703","DOI":"10.1039\/D3NA00280B","volume":"5","author":"A Music\u00f2","year":"2023","unstructured":"Music\u00f2 A, Zenatelli R, Romano M, Zendrini A, Alacqua S, Tassoni S, et al. Surface functionalization of extracellular vesicle nanoparticles with antibodies: a first study on the protein corona variable. Nanoscale Adv. 2023;5(18):4703\u201317. https:\/\/doi.org\/10.1039\/D3NA00280B.","journal-title":"Nanoscale Adv"},{"issue":"3","key":"4628_CR30","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nmeth.4185","volume":"14","author":"J Van Deun","year":"2017","unstructured":"Van Deun J, Mestdagh P, Agostinis P, Akay \u00d6, Anand S, Anckaert J, et al. EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research. Nat Methods. 2017;14(3):228\u201332. https:\/\/doi.org\/10.1038\/nmeth.4185.","journal-title":"Nat Methods"},{"issue":"1","key":"4628_CR31","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1038\/s41467-018-04791-8","volume":"9","author":"WM Usman","year":"2018","unstructured":"Usman WM, Pham TC, Kwok YY, Vu LT, Ma V, Peng B, et al. Efficient RNA drug delivery using red blood cell extracellular vesicles. Nat Commun. 2018;9(1):2359. https:\/\/doi.org\/10.1038\/s41467-018-04791-8.","journal-title":"Nat Commun"},{"key":"4628_CR32","doi-asserted-by":"publisher","first-page":"452","DOI":"10.3389\/fbioe.2019.00452","volume":"7","author":"A Zendrini","year":"2020","unstructured":"Zendrini A, Paolini L, Busatto S, Radeghieri A, Romano M, Wauben MHM, et al. Augmented COlorimetric NANoplasmonic (CONAN) Method for Grading Purity and Determine Concentration of EV Microliter Volume Solutions. Front Bioeng Biotechnol. 2020;7:452. https:\/\/doi.org\/10.3389\/fbioe.2019.00452.","journal-title":"Front Bioeng Biotechnol"},{"issue":"1","key":"4628_CR33","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1186\/s12935-021-02135-z","volume":"21","author":"L Signati","year":"2021","unstructured":"Signati L, Allevi R, Piccotti F, Albasini S, Villani L, Sevieri M, et al. Ultrastructural analysis of breast cancer patient-derived organoids. Cancer Cell Int. 2021;21(1):423. https:\/\/doi.org\/10.1186\/s12935-021-02135-z.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"4628_CR34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12575-019-0099-8","volume":"21","author":"S Mazzucchelli","year":"2019","unstructured":"Mazzucchelli S, Piccotti F, Allevi R, Truffi M, Sorrentino L, Russo L, et al. Establishment and Morphological Characterization of Patient-Derived Organoids from Breast Cancer. Biol Proced Online. 2019;21(1):12. https:\/\/doi.org\/10.1186\/s12575-019-0099-8.","journal-title":"Biol Proced Online"},{"issue":"8","key":"4628_CR35","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1042\/BCJ20170897","volume":"475","author":"G Alvisi","year":"2018","unstructured":"Alvisi G, Paolini L, Contarini A, Zambarda C, Di Antonio V, Colosini A, et al. Intersectin goes nuclear: secret life of an endocytic protein. Biochem J. 2018;475(8):1455\u201372. https:\/\/doi.org\/10.1042\/BCJ20170897.","journal-title":"Biochem J"},{"issue":"1","key":"4628_CR36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15\u201321. https:\/\/doi.org\/10.1093\/bioinformatics\/bts635.","journal-title":"Bioinformatics"},{"issue":"2","key":"4628_CR37","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders S, Pyl PT, Huber W. HTSeq\u2014a Python framework to work with high-throughput sequencing data. Bioinformatics. 2015;31(2):166\u20139. https:\/\/doi.org\/10.1093\/bioinformatics\/btu638.","journal-title":"Bioinformatics"},{"issue":"12","key":"4628_CR38","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8.","journal-title":"Genome Biol"},{"issue":"9","key":"4628_CR39","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/nbt.2931","volume":"32","author":"D Risso","year":"2014","unstructured":"Risso D, Ngai J, Speed TP, Dudoit S. Normalization of RNA-seq data using factor analysis of control genes or samples. Nat Biotechnol. 2014;32(9):896\u2013902. https:\/\/doi.org\/10.1038\/nbt.2931.","journal-title":"Nat Biotechnol"},{"issue":"5","key":"4628_CR40","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters. OMICS J Integr Biol. 2012;16(5):284\u20137. https:\/\/doi.org\/10.1089\/omi.2011.0118.","journal-title":"OMICS J Integr Biol"},{"issue":"11","key":"4628_CR41","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1111\/j.1600-0854.2011.01262.x","volume":"12","author":"L Paolini","year":"2011","unstructured":"Paolini L, Radeghieri A, Civini S, Caimi L, Ricotta D. The Epsilon Hinge-Ear Region Regulates Membrane Localization of the AP\u20104 Complex. Traffic. 2011;12(11):1604\u201319. https:\/\/doi.org\/10.1111\/j.1600-0854.2011.01262.x.","journal-title":"Traffic"},{"key":"4628_CR42","doi-asserted-by":"publisher","unstructured":"Dai Z, Zhang W, Zhou L, Huang J. Probing Lipid Peroxidation in Ferroptosis: Emphasizing the Utilization of C11-BODIPY-Based Protocols. In: Kroemer G, Tang D, editors. Ferroptosis [Internet]. New York, NY: Springer US; 2023 [cited 2026 Jan 5]. pp. 61\u201372. (Methods in Molecular Biology). Available from: https:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/978-1-0716-3433-2_6 doi:10.1007\/978-1-0716-3433-2_6.","DOI":"10.1007\/978-1-0716-3433-2_6"},{"key":"4628_CR43","doi-asserted-by":"publisher","unstructured":"Kroemer G, Tang D, editors. Ferroptosis: Methods and Protocols [Internet]. Vol. 2712. New York, NY: Springer US; 2023 [cited 2026 Jan 5]. (Methods in Molecular Biology). Available from: https:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/978-1-0716-3433-2 doi:10.1007\/978-1-0716-3433-2.","DOI":"10.1007\/978-1-0716-3433-2"},{"issue":"3","key":"4628_CR44","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/S0014-5793(99)00696-1","volume":"453","author":"EHW Pap","year":"1999","unstructured":"Pap EHW, Drummen GPC, Winter VJ, Kooij TWA, Rijken P, Wirtz KWA, et al. Ratio-fluorescence microscopy of lipid oxidation in living cells using C11\u2010BODIPY581\/591. FEBS Lett. 1999;453(3):278\u201382. https:\/\/doi.org\/10.1016\/S0014-5793(99)00696-1.","journal-title":"FEBS Lett"},{"issue":"3","key":"4628_CR45","doi-asserted-by":"publisher","first-page":"102457","DOI":"10.1016\/j.xpro.2023.102457","volume":"4","author":"MB Murray","year":"2023","unstructured":"Murray MB, Leak LB, Lee WC, Dixon SJ. Protocol for detection of ferroptosis in cultured cells. STAR Protoc. 2023;4(3):102457. https:\/\/doi.org\/10.1016\/j.xpro.2023.102457.","journal-title":"STAR Protoc"},{"issue":"1","key":"4628_CR46","doi-asserted-by":"publisher","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","volume":"7","author":"C Th\u00e9ry","year":"2018","unstructured":"Th\u00e9ry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7(1):1535750. https:\/\/doi.org\/10.1080\/20013078.2018.1535750.","journal-title":"J Extracell Vesicles"},{"issue":"2","key":"4628_CR47","doi-asserted-by":"publisher","first-page":"e12404","DOI":"10.1002\/jev2.12404","volume":"13","author":"JA Welsh","year":"2024","unstructured":"Welsh JA, Goberdhan DCI, O\u2019Driscoll L, Buzas EI, Blenkiron C, Bussolati B, et al. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. J Extracell Vesicles. 2024;13(2):e12404. https:\/\/doi.org\/10.1002\/jev2.12404.","journal-title":"J Extracell Vesicles"},{"issue":"29","key":"4628_CR48","doi-asserted-by":"publisher","first-page":"2400533","DOI":"10.1002\/advs.202400533","volume":"11","author":"A Gori","year":"2024","unstructured":"Gori A, Frigerio R, Gagni P, Burrello J, Panella S, Raimondi A, et al. Addressing Heterogeneity in Direct Analysis of Extracellular Vesicles and Their Analogs by Membrane Sensing Peptides as Pan-Vesicular Affinity Probes. Adv Sci. 2024;11(29):2400533. https:\/\/doi.org\/10.1002\/advs.202400533.","journal-title":"Adv Sci"},{"key":"4628_CR49","doi-asserted-by":"publisher","DOI":"10.1039\/D4NH00320A","author":"A Music\u00f2","year":"2024","unstructured":"Music\u00f2 A, Zendrini A, Reyes SG, Mangolini V, Paolini L, Romano M, et al. Extracellular vesicles of different cellular origin feature distinct biomolecular corona dynamics. Nanoscale Horiz. 2024. https:\/\/doi.org\/10.1039\/D4NH00320A.","journal-title":"Nanoscale Horiz"},{"issue":"4","key":"4628_CR50","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3109\/08982104.2015.1127257","volume":"26","author":"P Ringhieri","year":"2016","unstructured":"Ringhieri P, Pannunzio A, Boccarelli A, Morelli G, Coluccia M, Tesauro D. Effect of cisplatin containing liposomes formulated by unsaturated chain-containing lipids on gynecological tumor cells. J Liposome Res. 2016;26(4):307\u201312. https:\/\/doi.org\/10.3109\/08982104.2015.1127257.","journal-title":"J Liposome Res"},{"key":"4628_CR51","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ejpb.2019.11.010","volume":"146","author":"E Schulz","year":"2020","unstructured":"Schulz E, Karagianni A, Koch M, Fuhrmann G. Hot EVs \u2013 How temperature affects extracellular vesicles. Eur J Pharm Biopharm. 2020;146:55\u201363. https:\/\/doi.org\/10.1016\/j.ejpb.2019.11.010.","journal-title":"Eur J Pharm Biopharm"},{"issue":"5","key":"4628_CR52","doi-asserted-by":"publisher","first-page":"2100047","DOI":"10.1002\/adhm.202100047","volume":"11","author":"BF Hettich","year":"2022","unstructured":"Hettich BF, Bader JJ, Leroux J. Encapsulation of Hydrophilic Compounds in Small Extracellular Vesicles: Loading Capacity and Impact on Vesicle Functions. Adv Healthc Mater. 2022;11(5):2100047. https:\/\/doi.org\/10.1002\/adhm.202100047.","journal-title":"Adv Healthc Mater"},{"issue":"2","key":"4628_CR53","doi-asserted-by":"publisher","first-page":"857","DOI":"10.21873\/anticanres.15543","volume":"42","author":"G Go","year":"2022","unstructured":"Go G, Park HJ, Lee JH, Yun CW, Lee SH. Inhibitory Effect of Oxaliplatin-loaded Engineered Milk Extracellular Vesicles on Tumor Progression. Anticancer Res. 2022;42(2):857\u201366. https:\/\/doi.org\/10.21873\/anticanres.15543.","journal-title":"Anticancer Res"},{"key":"4628_CR54","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.3389\/fphys.2018.01898","volume":"9","author":"N Martinho","year":"2019","unstructured":"Martinho N, Santos TCB, Florindo HF, Silva LC. Cisplatin-Membrane Interactions and Their Influence on Platinum Complexes Activity and Toxicity. Front Physiol. 2019;9:1898. https:\/\/doi.org\/10.3389\/fphys.2018.01898.","journal-title":"Front Physiol"},{"issue":"10","key":"4628_CR55","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1021\/tx049868j","volume":"17","author":"R Mandal","year":"2004","unstructured":"Mandal R, Kalke R, Li XF. Interaction of Oxaliplatin, Cisplatin, and Carboplatin with Hemoglobin and the Resulting Release of a Heme Group. Chem Res Toxicol. 2004;17(10):1391\u20137. https:\/\/doi.org\/10.1021\/tx049868j.","journal-title":"Chem Res Toxicol"},{"issue":"8","key":"4628_CR56","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.nano.2013.04.010","volume":"9","author":"F Wang","year":"2013","unstructured":"Wang F, Yu L, Monopoli MP, Sandin P, Mahon E, Salvati A, et al. The biomolecular corona is retained during nanoparticle uptake and protects the cells from the damage induced by cationic nanoparticles until degraded in the lysosomes. Nanomed Nanotechnol Biol Med. 2013;9(8):1159\u201368. https:\/\/doi.org\/10.1016\/j.nano.2013.04.010.","journal-title":"Nanomed Nanotechnol Biol Med"},{"issue":"12","key":"4628_CR57","doi-asserted-by":"publisher","first-page":"12384","DOI":"10.1002\/jev2.12384","volume":"12","author":"L Loconte","year":"2023","unstructured":"Loconte L, Arguedas D, El R, Zhou A, Chipont A, Guyonnet L, et al. Detection of the interactions of tumour derived extracellular vesicles with immune cells is dependent on EV-labelling methods. J Extracell Vesicles. 2023;12(12):12384. https:\/\/doi.org\/10.1002\/jev2.12384.","journal-title":"J Extracell Vesicles"},{"issue":"2","key":"4628_CR58","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.18632\/oncotarget.2741","volume":"6","author":"S Liang","year":"2015","unstructured":"Liang S, Peng X, Li X, Yang P, Xie L, Li Y, et al. Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin. Oncotarget. 2015;6(2):1020\u201330. https:\/\/doi.org\/10.18632\/oncotarget.2741.","journal-title":"Oncotarget"},{"issue":"3","key":"4628_CR59","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/trf.17271","volume":"63","author":"J Oh","year":"2023","unstructured":"Oh J, Marques MB, Xu X, Li J, Genschmer KR, Phillips E, et al. Different-sized extracellular vesicles derived from stored red blood cells package diverse cargoes and cause distinct cellular effects. Transfus (Paris). 2023;63(3):586\u2013600. https:\/\/doi.org\/10.1111\/trf.17271.","journal-title":"Transfus (Paris)"},{"issue":"1","key":"4628_CR60","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13058-015-0662-4","volume":"18","author":"T Tanei","year":"2016","unstructured":"Tanei T, Choi DS, Rodriguez AA, Liang DH, Dobrolecki L, Ghosh M, et al. Antitumor activity of Cetuximab in combination with Ixabepilone on triple negative breast cancer stem cells. Breast Cancer Res. 2016;18(1):6. https:\/\/doi.org\/10.1186\/s13058-015-0662-4.","journal-title":"Breast Cancer Res"},{"issue":"4","key":"4628_CR61","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3785\/j.issn.1008-9292","volume":"40","author":"Xyi Sun","year":"2011","unstructured":"Sun Xyi, Liang W. quan. [Comparison on antitumor activity of cisplatin-loaded liposomes and nanoparticles in vitro]. Zhejiang Xue Xue Bao Yi Xue Ban J Zhejiang Univ Med Sci. 2011;40(4):408\u201313. https:\/\/doi.org\/10.3785\/j.issn.1008-9292. 2011.04.011 PubMed PMID: 21845755.","journal-title":"Zhejiang Xue Xue Bao Yi Xue Ban J Zhejiang Univ Med Sci"},{"issue":"6","key":"4628_CR62","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1039\/c3mt20251h","volume":"5","author":"G Hermann","year":"2013","unstructured":"Hermann G, Heffeter P, Falta T, Berger W, Hann S, Koellensperger G. In vitro studies on cisplatin focusing on kinetic aspects of intracellular chemistry by LC-ICP-MS. Metallomics. 2013;5(6):636. https:\/\/doi.org\/10.1039\/c3mt20251h.","journal-title":"Metallomics"},{"issue":"8","key":"4628_CR63","doi-asserted-by":"publisher","first-page":"e42522","DOI":"10.1371\/journal.pone.0042522","volume":"7","author":"EC Filippi-Chiela","year":"2012","unstructured":"Filippi-Chiela EC, Oliveira MM, Jurkovski B, Callegari-Jacques SM, Silva VDD, Lenz G. Nuclear Morphometric Analysis (NMA): Screening of Senescence, Apoptosis and Nuclear Irregularities. Lebedeva IV. editor PLoS ONE. 2012;7(8):e42522. https:\/\/doi.org\/10.1371\/journal.pone.0042522.","journal-title":"editor PLoS ONE"},{"issue":"7","key":"4628_CR64","doi-asserted-by":"publisher","first-page":"e00648","DOI":"10.1128\/MCB.00648-20","volume":"41","author":"ER Smith","year":"2021","unstructured":"Smith ER, Leal J, Amaya C, Li B, Xu XX. Nuclear Lamin A\/C Expression Is a Key Determinant of Paclitaxel Sensitivity. Mol Cell Biol. 2021;41(7):e00648\u201320. https:\/\/doi.org\/10.1128\/MCB.00648-20.","journal-title":"Mol Cell Biol"},{"issue":"9","key":"4628_CR65","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.3390\/cells9091931","volume":"9","author":"D Corbeil","year":"2020","unstructured":"Corbeil D, Santos MF, Karbanov\u00e1 J, Kurth T, Rappa G, Lorico A. Uptake and Fate of Extracellular Membrane Vesicles: Nucleoplasmic Reticulum-Associated Late Endosomes as a New Gate to Intercellular Communication. Cells. 2020;9(9):1931. https:\/\/doi.org\/10.3390\/cells9091931.","journal-title":"Cells"},{"issue":"9","key":"4628_CR66","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.3390\/biomedicines9091265","volume":"9","author":"CH Li","year":"2021","unstructured":"Li CH, Hsu TI, Chang YC, Chan MH, Lu PJ, Hsiao M. Stationed or Relocating: The Seesawing EMT\/MET Determinants from Embryonic Development to Cancer Metastasis. Biomedicines. 2021;9(9):1265. https:\/\/doi.org\/10.3390\/biomedicines9091265.","journal-title":"Biomedicines"},{"issue":"4","key":"4628_CR67","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s41419-022-04756-2","volume":"13","author":"Z Lu","year":"2022","unstructured":"Lu Z, Yuan S, Ruan L, Tu Z, Liu H. Partitioning defective 6 homolog alpha (PARD6A) promotes epithelial\u2013mesenchymal transition via integrin \u03b21-ILK-SNAIL1 pathway in ovarian cancer. Cell Death Dis. 2022;13(4):304. https:\/\/doi.org\/10.1038\/s41419-022-04756-2.","journal-title":"Cell Death Dis"},{"issue":"16","key":"4628_CR68","doi-asserted-by":"publisher","first-page":"8885","DOI":"10.3390\/ijms22168885","volume":"22","author":"J Kryczka","year":"2021","unstructured":"Kryczka J, Kryczka J, Czarnecka-Chrebelska KH, Brzezia\u0144ska-Lasota E. Molecular Mechanisms of Chemoresistance Induced by Cisplatin in NSCLC Cancer Therapy. Int J Mol Sci. 2021;22(16):8885. https:\/\/doi.org\/10.3390\/ijms22168885.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4628_CR69","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s13238-020-00742-6","volume":"12","author":"L Xu","year":"2021","unstructured":"Xu L, Li P, Hao X, Lu Y, Liu M, Song W, et al. SHANK2 is a frequently amplified oncogene with evolutionarily conserved roles in regulating Hippo signaling. Protein Cell. 2021;12(3):174\u201393. https:\/\/doi.org\/10.1007\/s13238-020-00742-6.","journal-title":"Protein Cell"},{"issue":"24","key":"4628_CR70","doi-asserted-by":"publisher","first-page":"5728","DOI":"10.3390\/cancers15245728","volume":"15","author":"R Malla","year":"2023","unstructured":"Malla R, Kundrapu DB, Bhamidipati P, Nagaraju GP, Muniraj N. Unleashing the Power of Yes-Associated Protein in Ferroptosis and Drug Resistance in Breast Cancer, with a Special Focus on Therapeutic Strategies. Cancers. 2023;15(24):5728. https:\/\/doi.org\/10.3390\/cancers15245728.","journal-title":"Cancers"},{"issue":"21","key":"4628_CR71","doi-asserted-by":"publisher","first-page":"5474","DOI":"10.3390\/cancers13215474","volume":"13","author":"J Kim","year":"2021","unstructured":"Kim J, Jang G, Sim SH, Park IH, Kim K, Park C. SMARCA4 Depletion Induces Cisplatin Resistance by Activating YAP1-Mediated Epithelial-to-Mesenchymal Transition in Triple-Negative Breast Cancer. Cancers. 2021;13(21):5474. https:\/\/doi.org\/10.3390\/cancers13215474.","journal-title":"Cancers"},{"issue":"1","key":"4628_CR72","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s12885-015-1259-0","volume":"15","author":"M Gabriel","year":"2015","unstructured":"Gabriel M, Delforge Y, Deward A, Habraken Y, Hennuy B, Piette J, et al. Role of the splicing factor SRSF4 in cisplatin-induced modifications of pre-mRNA splicing and apoptosis. BMC Cancer. 2015;15(1):227. https:\/\/doi.org\/10.1186\/s12885-015-1259-0.","journal-title":"BMC Cancer"},{"key":"4628_CR73","doi-asserted-by":"publisher","unstructured":"Cheng H, Sharen G, Wang Z, Zhou J. LncRNA UCA1 Enhances Cisplatin Resistance by Regulating CYP1B1-mediated Apoptosis via miR-513a-3p in Human Gastric Cancer. Cancer Manag Res 2021;Volume 13:367\u201377. https:\/\/doi.org\/10.2147\/CMAR.S277399","DOI":"10.2147\/CMAR.S277399"},{"key":"4628_CR74","doi-asserted-by":"publisher","first-page":"103843","DOI":"10.1016\/j.redox.2025.103843","volume":"86","author":"D Han","year":"2025","unstructured":"Han D, Wang T, Li X, Qin C, Zhang Y, Zhou T, et al. Small extracellular vesicles orchestrated pathological communications between breast cancer cells and cardiomyocytes as a novel mechanism exacerbating anthracycline cardiotoxicity by fueling ferroptosis. Redox Biol. 2025;86:103843. https:\/\/doi.org\/10.1016\/j.redox.2025.103843.","journal-title":"Redox Biol"},{"issue":"23","key":"4628_CR75","doi-asserted-by":"publisher","first-page":"4334","DOI":"10.1016\/j.molcel.2023.10.025","volume":"83","author":"D Lv","year":"2023","unstructured":"Lv D, Zhong C, Dixit D, Yang K, Wu Q, Godugu B, et al. EGFR promotes ALKBH5 nuclear retention to attenuate N6-methyladenosine and protect against ferroptosis in glioblastoma. Mol Cell. 2023;83(23):4334\u2013e43517. https:\/\/doi.org\/10.1016\/j.molcel.2023.10.025.","journal-title":"Mol Cell"},{"key":"4628_CR76","doi-asserted-by":"publisher","unstructured":"Kwon YJ, Baek HS, Ye DJ, Shin S, Kim D, Chun YJ. CYP1B1 Enhances Cell Proliferation and Metastasis through Induction of EMT and Activation of Wnt\/\u03b2-Catenin Signaling via Sp1 Upregulation. Katoh M, editor. PLOS ONE. 2016;11(3):e0151598. https:\/\/doi.org\/10.1371\/journal.pone.0151598","DOI":"10.1371\/journal.pone.0151598"},{"issue":"1","key":"4628_CR77","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1038\/s41467-023-39401-9","volume":"14","author":"Y Yan","year":"2023","unstructured":"Yan Y, Teng H, Hang Q, Kondiparthi L, Lei G, Horbath A, et al. SLC7A11 expression level dictates differential responses to oxidative stress in cancer cells. Nat Commun. 2023;14(1):3673. https:\/\/doi.org\/10.1038\/s41467-023-39401-9.","journal-title":"Nat Commun"},{"issue":"1","key":"4628_CR78","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12575-023-00199-x","volume":"25","author":"B Tang","year":"2023","unstructured":"Tang B, Wang Y, Zhu J, Song J, Fang S, Weng Q, et al. TACE responser NDRG1 acts as a guardian against ferroptosis to drive tumorgenesis and metastasis in HCC. Biol Proced Online. 2023;25(1):13. https:\/\/doi.org\/10.1186\/s12575-023-00199-x.","journal-title":"Biol Proced Online"},{"key":"4628_CR79","doi-asserted-by":"publisher","first-page":"5429","DOI":"10.2147\/OTT.S254995","volume":"13","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Li Y, Zhang R, Wang F, Wang T, Jiao Y. The Role of Erastin in Ferroptosis and Its Prospects in Cancer Therapy. OncoTargets Ther. 2020;13:5429\u201341. https:\/\/doi.org\/10.2147\/OTT.S254995.","journal-title":"OncoTargets Ther"},{"issue":"7","key":"4628_CR80","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1038\/s44321-024-00090-6","volume":"16","author":"N Lorito","year":"2024","unstructured":"Lorito N, Subbiani A, Smiriglia A, Bacci M, Bonechi F, Tronci L, et al. FADS1\/2 control lipid metabolism and ferroptosis susceptibility in triple-negative breast cancer. EMBO Mol Med. 2024;16(7):1533\u201359. https:\/\/doi.org\/10.1038\/s44321-024-00090-6 . PubMed PMID: 38926633; PubMed Central PMCID: PMC11251055.","journal-title":"EMBO Mol Med"},{"issue":"2","key":"4628_CR81","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"D Tang","year":"2021","unstructured":"Tang D, Chen X, Kang R, Kroemer G. Ferroptosis: molecular mechanisms and health implications. Cell Res. 2021;31(2):107\u201325. https:\/\/doi.org\/10.1038\/s41422-020-00441-1.","journal-title":"Cell Res"},{"issue":"17","key":"4628_CR82","doi-asserted-by":"publisher","first-page":"13336","DOI":"10.3390\/ijms241713336","volume":"24","author":"X Zheng","year":"2023","unstructured":"Zheng X, Zhang C. The Regulation of Ferroptosis by Noncoding RNAs. Int J Mol Sci. 2023;24(17):13336. https:\/\/doi.org\/10.3390\/ijms241713336.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4628_CR83","doi-asserted-by":"publisher","first-page":"508","DOI":"10.7150\/ijms.104222","volume":"22","author":"S Cao","year":"2025","unstructured":"Cao S, Wei Y, Yue Y, Wang D, Xiong A, Zeng H. Deciphering Epigenetic and Post-Translational Modifications in Ferroptosis: A Scientometric and Visualization Study. Int J Med Sci. 2025;22(3):508\u201327. https:\/\/doi.org\/10.7150\/ijms.104222.","journal-title":"Int J Med Sci"},{"issue":"11","key":"4628_CR84","doi-asserted-by":"publisher","first-page":"5107","DOI":"10.7150\/thno.44705","volume":"10","author":"P Chen","year":"2020","unstructured":"Chen P, Li X, Zhang R, Liu S, Xiang Y, Zhang M, et al. Combinative treatment of \u03b2-elemene and cetuximab is sensitive to KRAS mutant colorectal cancer cells by inducing ferroptosis and inhibiting epithelial-mesenchymal transformation. Theranostics. 2020;10(11):5107\u201319. https:\/\/doi.org\/10.7150\/thno.44705.","journal-title":"Theranostics"},{"issue":"18","key":"4628_CR85","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.3390\/cells11182866","volume":"11","author":"J De Azevedo","year":"2022","unstructured":"De Azevedo J, Mourtada J, Bour C, Devignot V, Schultz P, Borel C, et al. The EXTREME Regimen Associating Cetuximab and Cisplatin Favors Head and Neck Cancer Cell Death and Immunogenicity with the Induction of an Anti-Cancer Immune Response. Cells. 2022;11(18):2866. https:\/\/doi.org\/10.3390\/cells11182866.","journal-title":"Cells"},{"issue":"4","key":"4628_CR86","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1172\/JCI117840","volume":"95","author":"PA Wood","year":"1995","unstructured":"Wood PA, Hrushesky WJ. Cisplatin-associated anemia: an erythropoietin deficiency syndrome. J Clin Invest. 1995;95(4):1650\u20139. https:\/\/doi.org\/10.1172\/JCI117840.","journal-title":"J Clin Invest"},{"issue":"6","key":"4628_CR87","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1023\/A:1013784115683","volume":"17","author":"D Khynriam","year":"2001","unstructured":"Khynriam D, Prasad SB. Hematotoxicity and blood glutathione levels after cisplatin treatment of tumor-bearing mice. Cell Biol Toxicol. 2001;17(6):357\u201370. https:\/\/doi.org\/10.1023\/A:1013784115683.","journal-title":"Cell Biol Toxicol"},{"issue":"8","key":"4628_CR88","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1093\/jjco\/hyr076","volume":"41","author":"M Ishizuka","year":"2011","unstructured":"Ishizuka M, Fujimoto Y, Itoh Y, Kitagawa K, Sano M, Miyagawa Y, et al. Relationship Between Hematotoxicity and Serum Albumin Level in the Treatment of Head and Neck Cancers with Concurrent Chemoradiotherapy Using Cisplatin. Jpn J Clin Oncol. 2011;41(8):973\u20139. https:\/\/doi.org\/10.1093\/jjco\/hyr076.","journal-title":"Jpn J Clin Oncol"},{"issue":"1","key":"4628_CR89","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/1556-276X-9-257","volume":"9","author":"M Kutwin","year":"2014","unstructured":"Kutwin M, Sawosz E, Jaworski S, Kurantowicz N, Strojny B, Chwalibog A. Structural damage of chicken red blood cells exposed to platinum nanoparticles and cisplatin. Nanoscale Res Lett. 2014;9(1):257. https:\/\/doi.org\/10.1186\/1556-276X-9-257.","journal-title":"Nanoscale Res Lett"},{"key":"4628_CR90","doi-asserted-by":"publisher","unstructured":"Aloi N, Bergese P, Bongiovanni A, Colombo P, Dominici M, Rivas J et al. D4.2 BOW products in vitro and ex vivo immunotoxicity\/genotoxicity [Internet]. 2023 Oct 31. https:\/\/doi.org\/10.5281\/ZENODO.14038641","DOI":"10.5281\/ZENODO.14038641"},{"key":"4628_CR91","doi-asserted-by":"publisher","unstructured":"Bergese P, Di Bucchianico S, Di Schiavi E, Romano M, Santonicola P, Trapani I. D4.4: evBOW products in C. elegans [Internet]. 2024 Apr 30. https:\/\/doi.org\/10.5281\/ZENODO.14038995","DOI":"10.5281\/ZENODO.14038995"},{"issue":"1","key":"4628_CR92","doi-asserted-by":"publisher","first-page":"13039","DOI":"10.1038\/s41598-018-31138-6","volume":"8","author":"TJ Puls","year":"2018","unstructured":"Puls TJ, Tan X, Husain M, Whittington CF, Fishel ML, Voytik-Harbin SL. Development of a Novel 3D Tumor-tissue Invasion Model for High-throughput, High-content Phenotypic Drug Screening. Sci Rep. 2018;8(1):13039. https:\/\/doi.org\/10.1038\/s41598-018-31138-6.","journal-title":"Sci Rep"},{"key":"4628_CR93","doi-asserted-by":"publisher","unstructured":"McCormick SC, Stillman N, Hockley M, Perriman AW, Hauert S. Measuring Nanoparticle Penetration Through Bio-Mimetic Gels. Int J Nanomed 2021;Volume 16:2585\u201395. https:\/\/doi.org\/10.2147\/IJN.S292131","DOI":"10.2147\/IJN.S292131"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04628-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04628-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04628-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T04:04:54Z","timestamp":1786593894000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04628-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,7]]},"references-count":93,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4628"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04628-3","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,7]]},"assertion":[{"value":"14 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Research was conducted in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) and Good Clinical Practice. The study was approved by the ethics committee of Spedali Civili di Brescia (Protocol number 5705). Patient derived organoids were obtained by Bruno Boerci Oncological Biobank, (ICS Maugeri IRCCS\u2019s ethical committee approvation of 27 July 2009).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all the subjects enrolled in the study. The privacy rights of subjects involved in the study have always been observed.","order":2,"name":"Ethics","label":"Patient consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"751"}}